OBJECTIVE: Determine the effect of endogenous estrogen versus estrogen replacement therapy (ERT) on bladder blood flow (BBF) and estrogen receptors (ERs). METHODS: BBF was determined with radiolabeled microspheres in luteal, follicular, pregnant, oophorectomized (Ovx) sheep, and Ovx sheep with ERT. Estrogen receptors (ERalpha, ERbeta) were quantified using Western blot analysis. RESULTS: Compared to luteal and follicular ewes, BBF was reduced in pregnancy and following oophorectomy. Estrogen replacement therapy in Ovx sheep restored BBF to luteal levels. Estrogen receptor alpha predominated, whereas ERbeta was not detectable. Estrogen receptor-alpha levels were unaffected by the ovarian cycle and increased in pregnancy, as well as in Ovx sheep with and without chronic ERT. CONCLUSION: The combination of diminished BBF and elevated ERalpha levels in both pregnant and Ovx sheep suggests an inverse relationship between BBF and ERalpha in the bladder. Although chronic ERT in Ovx sheep restored BBF, it did not restore ERalpha back to luteal levels.
OBJECTIVE: Determine the effect of endogenous estrogen versus estrogen replacement therapy (ERT) on bladder blood flow (BBF) and estrogen receptors (ERs). METHODS:BBF was determined with radiolabeled microspheres in luteal, follicular, pregnant, oophorectomized (Ovx) sheep, and Ovxsheep with ERT. Estrogen receptors (ERalpha, ERbeta) were quantified using Western blot analysis. RESULTS: Compared to luteal and follicular ewes, BBF was reduced in pregnancy and following oophorectomy. Estrogen replacement therapy in Ovxsheep restored BBF to luteal levels. Estrogen receptor alpha predominated, whereas ERbeta was not detectable. Estrogen receptor-alpha levels were unaffected by the ovarian cycle and increased in pregnancy, as well as in Ovxsheep with and without chronic ERT. CONCLUSION: The combination of diminished BBF and elevated ERalpha levels in both pregnant and Ovxsheep suggests an inverse relationship between BBF and ERalpha in the bladder. Although chronic ERT in Ovxsheep restored BBF, it did not restore ERalpha back to luteal levels.
Authors: H L Rupnow; T M Phernetton; C E Shaw; M L Modrick; I M Bird; R R Magness Journal: Am J Physiol Heart Circ Physiol Date: 2001-04 Impact factor: 4.733
Authors: J E Greenland; J J Hvistendahl; H Andersen; T M Jörgensen; G McMurray; M Cortina-Borja; A F Brading; J Frøkiaer Journal: BJU Int Date: 2000-06 Impact factor: 5.588
Authors: Mohamed A Ghafar; Ahmad Shabsigh; Paul Chichester; Aristotelis G Anastasiadis; Abby Borow; Robert M Levin; Ralph Buttyan Journal: J Urol Date: 2002-03 Impact factor: 7.450
Authors: Yung-Shun Juan; Anita Mannikarottu; Barry A Kogan; Robert E Leggett; Catherine Whitbeck; Paul Chichester; Wei-Yu Lin; Arnold Johnson; Robert M Levin Journal: Urology Date: 2008-03-04 Impact factor: 2.649
Authors: Yansheng Feng; Ngonidzashe B Madungwe; Carolina Victoria da Cruz Junho; Jean C Bopassa Journal: Br J Pharmacol Date: 2017-10-22 Impact factor: 8.739